Pfizer considers cost cuts as demand for Covid products falls

reuters.com

2 pointsmomirlan3 comments

it's the flip side of what we were seeing a few years ago. When a pandemic is peaking and demand is high for crucial medical tech, the price will ride the demand all the way to the max. Which will kill people if the price is too high. and it costs countries dearly to have to rely on private enterprise to provide essential public health services.

I think situations like pandemics which could end a civilization if a vaccine couldn't be distributed trumps the usual capitalist shell game of surge pricing.

It think it makes sense for countries to pay some kind of "retainer fee" to several companies for keeping up the ability to massively and quickly scale up production and distribution of e.g. mRNA-based vaccines for when it's needed, once every n decades.

Or maybe some hybrid model where governments some of the long term preparedness scaling preparedness aspects.

how to get boster?

Reply on news.ycombinator.com